ArticleGastroenterology research and practice2026
Identification of Symptom Clusters and Core Symptoms in Inflammatory Bowel Disease: A Network Analysis in Chinese Cohorts.
Article in Gastroenterology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of Symptom Clusters and Core Symptoms in Inflammatory Bowel Disease: A Network Analysis in Chinese Cohorts.Gastroenterology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Research on symptom clustering in patients with inflammatory bowel disease (IBD) using network analysis is limited. Core symptom clusters in Chinese patients with IBD have not been clearly defined, and comparative evidence between Crohn's disease (CD) and ulcerative colitis (UC) remains scarce, limiting the development of targeted symptom management strategies. Methods: Data were collected from three hospitals using the Chinese version of the symptom scale for IBD to assess symptom frequency, severity, and distress. Exploratory factor analysis was performed to identify symptom clusters. Symptom networks for CD and UC were constructed using JASP 0.19.1.0 to identify core and bridge symptoms. Bootstrap methods were applied to evaluate edge-weight accuracy and the stability of centrality indices. Results: Abdominal pain (78.3%) was the most prevalent symptom in patients with CD, whereas mucopurulent bloody stool (75.2%) was most common in patients with UC. Five symptom clusters were identified. In CD, diarrhea (Rs = 1.700) emerged as the core symptom, whereas diarrhea (Rb = 1.812) and abdominal pain (Rb = 1.812) functioned as bridge symptoms. In UC, weight loss (Rs = 1.421) was the core symptom, with nutritional deficiency serving as the primary bridge symptom (Rb = 1.931). Bootstrap analysis showed narrow confidence intervals for edge weights, and the stability coefficients for strength and closeness centrality exceeded 0.25, indicating robust and reliable networks. Conclusion: Five distinct symptom clusters were identified, and separate symptom networks were established for CD and UC. These findings provide evidence for disease-specific symptom prioritization and may support the development of targeted symptom management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.